These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25754587)

  • 21. Enhanced response of tamoxifen toward the cancer cells using a combination of chemotherapy and photothermal ablation induced by lentinan-functionalized multi-walled carbon nanotubes.
    Yi W; Zhang P; Hou J; Chen W; Bai L; Yoo S; Khalid A; Hou X
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1525-1532. PubMed ID: 30227209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
    Lai H; Nakase I; Lacoste E; Singh NP; Sasaki T
    Anticancer Res; 2009 Oct; 29(10):3807-10. PubMed ID: 19846912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer.
    Shi J; Wang Z; Wang L; Wang H; Li L; Yu X; Zhang J; Ma R; Zhang Z
    Int J Nanomedicine; 2013; 8():1551-62. PubMed ID: 23637528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.
    Zhang YJ; Zhan X; Wang L; Ho RJ; Sasaki T
    J Pharm Sci; 2015 May; 104(5):1815-24. PubMed ID: 25753991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
    Datir SR; Das M; Singh RP; Jain S
    Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
    Liu K; Dai L; Li C; Liu J; Wang L; Lei J
    Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
    Yao J; Zhang L; Zhou J; Liu H; Zhang Q
    Mol Pharm; 2013 Mar; 10(3):1080-91. PubMed ID: 23320642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of synergistic therapy system with multiple therapeutic effects based on CuS@Tf nanodots.
    Zhu C; Yin X; Li X; Wang Y
    J Inorg Biochem; 2020 Aug; 209():111100. PubMed ID: 32502874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.
    Fox JM; Moynihan JR; Mott BT; Mazzone JR; Anders NM; Brown PA; Rudek MA; Liu JO; Arav-Boger R; Posner GH; Civin CI; Chen X
    Oncotarget; 2016 Feb; 7(6):7268-79. PubMed ID: 26771236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
    Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
    Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted single-walled carbon nanotubes system.
    Zhang H; Hou L; Jiao X; Yandan J; Zhu X; Hongji L; Chen X; Ren J; Xia Y; Zhang Z
    Curr Pharm Biotechnol; 2014; 14(13):1105-17. PubMed ID: 24725129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy.
    Wang L; Hu Y; Hao Y; Li L; Zheng C; Zhao H; Niu M; Yin Y; Zhang Z; Zhang Y
    J Control Release; 2018 Sep; 286():74-84. PubMed ID: 30026078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.